LAS VEGAS, Dec. 16, 2025 /PRNewswire/ -- Avant Technologies, Inc. (OTCQB: AVAI) ("Avant" or the "Company"), an emerging biotechnology company focused on developing cell-based therapies for diabetes ...
The gene therapy market is surging toward $36.55 billion by 2032, powered by rising demand for curative treatments that ...
The PV industry is experiencing rapid technological evolution. Emerging cell technologies are driving deeper synergy between PV modules and encapsulation materials. While different technical routes ...
Detailed price information for Bioage Labs Inc (BIOA-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback